Short-term response might influence the treatment-related benefit of adjuvant chemotherapy after concurrent chemoradiotherapy for esophageal squamous cell carcinoma patients

BACKGROUND: Whether adjuvant chemotherapy (AC) after concurrent chemoradiotherapy (CCRT) could provide benefit to esophageal squamous cell carcinoma (ESCC) patients is controversial. Therefore, we decided to investigate the potential benefit of AC after CCRT for ESCC and to identify biomarkers predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ao, Wang, Yalin, Wang, Xin, Zhu, Liqiong, Nie, Yu, Li, Minghuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487511/
https://www.ncbi.nlm.nih.gov/pubmed/34600574
http://dx.doi.org/10.1186/s13014-021-01921-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487511/
https://www.ncbi.nlm.nih.gov/pubmed/34600574
http://dx.doi.org/10.1186/s13014-021-01921-3

Ejemplares similares